Explore

Trendline Trendline
FDA Approves Bemotrizinol, Expanding Sunscreen Options in the U.S.

FDA Approves Bemotrizinol, Expanding Sunscreen Options in the U.S.

FDA Approves Bemotrizinol, Expanding Sunscreen Options in the U.S.
Rapid Read Rapid Read
FDA Approves Bemotrizinol as First New Sunscreen Ingredient in Over 25 Years, Enhancing U.S. Sun Protection

FDA Approves Bemotrizinol as First New Sunscreen Ingredient in Over 25 Years, Enhancing U.S. Sun Protection

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol, marking the first new sunscreen ingredient allowed in the U.S. market in more than 25 years. Bemotrizinol, a chemical UV filter, has been used in European and Asian sunscreens for over two decades. It offers protection against both UVA and UVB rays, which are responsible for skin cancer and wrinkles. The approval is seen as a significant advancement in U.S. sunscreen technology, which has lagged behind due to regulatory hurdles. The ingredient will be marketed under the brand name Parsol Shield by DSM Nutritional Products, with an 18-month exclusivity period before other manufacturers can use it.
Vox Vox
The US just got its first new sunscreen in almost 30 years

The US just got its first new sunscreen in almost 30 years

America’s sunscreens have been stuck in the past. With BEMT, that's finally changing.
Trendline Trendline
FDA Approves First New Sunscreen Ingredient in Over 25 Years for U.S. Market

FDA Approves First New Sunscreen Ingredient in Over 25 Years for U.S. Market

FDA Approves First New Sunscreen Ingredient in Over 25 Years for U.S. Market
AP News AP News
FDA OKs first new sunscreen ingredient in more than 25 years

FDA OKs first new sunscreen ingredient in more than 25 years

Federal health regulators have signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years
Rapid Read Rapid Read
FDA Approves Bemotrizinol, First New Sunscreen Ingredient in the U.S. in Decades

FDA Approves Bemotrizinol, First New Sunscreen Ingredient in the U.S. in Decades

The United States has approved bemotrizinol, a new sunscreen ingredient, marking the first such approval in nearly 30 years. Bemotrizinol, known as BEMT, has been used in Europe and Asia but was delayed in the U.S. due to regulatory processes. The FDA's approval follows a congressional mandate to overhaul the sunscreen approval process. BEMT offers broad-spectrum protection against UVA and UVB rays and is expected to be more cosmetically appealing, addressing concerns about chemical sunscreens. The Environmental Working Group and dermatologists have hailed this approval as a significant advancement in sun protection.
Trendline Trendline
FDA Approves Bemotrizinol, a Popular Korean Sunscreen Ingredient, for U.S. Use

FDA Approves Bemotrizinol, a Popular Korean Sunscreen Ingredient, for U.S. Use

FDA Approves Bemotrizinol, a Popular Korean Sunscreen Ingredient, for U.S. Use
Rapid Read Rapid Read
FDA Approves Bemotrizinol, Expanding Sunscreen Options for U.S. Consumers

FDA Approves Bemotrizinol, Expanding Sunscreen Options for U.S. Consumers

The Food and Drug Administration (FDA) has approved bemotrizinol, a new sunscreen ingredient, marking the first addition to the list of approved sunscreen filters in over 20 years. Bemotrizinol, which has been used in Europe and Asia for decades, is recognized for its ability to protect against both UVA and UVB rays. The ingredient is considered Generally Recognized As Safe and Effective (GRASE) by the FDA and is suitable for use by adults and children over six months old. This approval is expected to enhance the effectiveness of U.S. sunscreens, which have traditionally been less effective against UVA rays compared to their international counterparts.
Rapid Read Rapid Read
FDA Adds Bemotrizinol to Approved Sunscreen Filters, Boosting UV Defense

FDA Adds Bemotrizinol to Approved Sunscreen Filters, Boosting UV Defense

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol as a new sunscreen filter, the first addition in over two decades. This chemical UV filter, already used in Europe, offers broader protection against UV light, including long-wave UVA rays, which are associated with skin cancer. Dermatologists in the U.S. are optimistic about the ingredient's potential to enhance sunscreen efficacy, as it is photostable and less likely to irritate sensitive skin. The approval aligns with efforts to modernize U.S. sunscreen regulations and improve consumer access to advanced sun protection.
Rapid Read Rapid Read
FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Ingredient Options

FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Ingredient Options

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol for use in American sunscreens, marking the first new active ingredient approval since the 1990s. Bemotrizinol is a chemical compound that provides broad-spectrum protection against UVA and UVB rays. It has been used in Europe and Asia for decades and is known for its stability and low absorption into the body. The approval process was expedited under the CARES Act, which aims to streamline the approval of over-the-counter drugs. Health and Human Services Secretary Robert F. Kennedy Jr. stated that this move will enhance competition and consumer confidence in sunscreen products.
Rapid Read Rapid Read
FDA Approves Bemotrizinol as New Sunscreen Ingredient, Enhancing UV Protection

FDA Approves Bemotrizinol as New Sunscreen Ingredient, Enhancing UV Protection

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol as a new active ingredient for over-the-counter sunscreens, marking the first such approval in over two decades. Bemotrizinol, which has been used safely in Europe for years, is recognized for its ability to protect against both UVA and UVB rays. The ingredient is considered Generally Recognized As Safe and Effective (GRASE) by the FDA and is suitable for use by adults and children aged six months and older. This approval is expected to increase competition and consumer confidence in sunscreen products in the U.S., providing stronger broad-spectrum protection against harmful UV rays.
Rapid Read Rapid Read
FDA Approves New Sunscreen Ingredient Bemotrizinol for U.S. Market

FDA Approves New Sunscreen Ingredient Bemotrizinol for U.S. Market

The Food and Drug Administration (FDA) has approved bemotrizinol, marking the first new sunscreen ingredient to enter the U.S. market in over 25 years. This ingredient, already used in Europe, offers protection against both UVA and UVB rays without the white residue associated with mineral-based sunscreens. Bemotrizinol will be marketed under the brand name Parsol Shield by DSM Nutritional Products, a Dutch manufacturer, and will be available later this year. The approval follows a streamlined process authorized by Congress in 2020, aimed at updating the FDA's list of safe nonprescription drug ingredients. The ingredient is deemed safe for adults and children over six months old.